BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20547213)

  • 1. Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders.
    Ramos KM; Lewis MT; Morgan KN; Crysdale NY; Kroll JL; Taylor FR; Harrison JA; Sloane EM; Maier SF; Watkins LR
    Neuroscience; 2010 Sep; 169(4):1888-900. PubMed ID: 20547213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of GLT-1 by treatment with ceftriaxone alleviates radicular pain by reducing spinal astrocyte activation and neuronal hyperexcitability.
    Nicholson KJ; Gilliland TM; Winkelstein BA
    J Neurosci Res; 2014 Jan; 92(1):116-29. PubMed ID: 24123246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anti-nociceptive role for ceftriaxone in chronic neuropathic pain in rats.
    Hu Y; Li W; Lu L; Cai J; Xian X; Zhang M; Li Q; Li L
    Pain; 2010 Feb; 148(2):284-301. PubMed ID: 20022427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The β-lactam clavulanic acid mediates glutamate transport-sensitive pain relief in a rat model of neuropathic pain.
    Kristensen PJ; Gegelashvili G; Munro G; Heegaard AM; Bjerrum OJ
    Eur J Pain; 2018 Feb; 22(2):282-294. PubMed ID: 28984398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The beta-lactam antibiotic, ceftriaxone, inhibits the development of opioid-induced hyperalgesia in mice.
    Chen Z; He Y; Wang ZJ
    Neurosci Lett; 2012 Feb; 509(2):69-71. PubMed ID: 22212402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate prevents dysregulation of spinal glutamate and reduces the development of hypersensitivity in rats after peripheral nerve injury.
    Yoshizumi M; Eisenach JC; Hayashida K
    J Pain; 2013 Nov; 14(11):1485-91. PubMed ID: 24021575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer of GLT-1, a glial glutamate transporter, into the spinal cord by recombinant adenovirus attenuates inflammatory and neuropathic pain in rats.
    Maeda S; Kawamoto A; Yatani Y; Shirakawa H; Nakagawa T; Kaneko S
    Mol Pain; 2008 Dec; 4():65. PubMed ID: 19108711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia/reperfusion injury.
    Verma R; Mishra V; Sasmal D; Raghubir R
    Eur J Pharmacol; 2010 Jul; 638(1-3):65-71. PubMed ID: 20423712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats.
    Sung B; Lim G; Mao J
    J Neurosci; 2003 Apr; 23(7):2899-910. PubMed ID: 12684477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone-mediated upregulation of the glutamate transporter GLT-1 contrasts neurotoxicity evoked by kainate in rat organotypic spinal cord cultures.
    Bajrektarevic D; Nistri A
    Neurotoxicology; 2017 May; 60():34-41. PubMed ID: 28257918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase 3 beta regulates glial glutamate transporter protein expression in the spinal dorsal horn in rats with neuropathic pain.
    Weng HR; Gao M; Maixner DW
    Exp Neurol; 2014 Feb; 252():18-27. PubMed ID: 24275526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-mediated downregulation of spinal astrocytic connexin43 leads to increased glutamatergic neurotransmission and neuropathic pain in mice.
    Morioka N; Zhang FF; Nakamura Y; Kitamura T; Hisaoka-Nakashima K; Nakata Y
    Brain Behav Immun; 2015 Oct; 49():293-310. PubMed ID: 26116449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of spinal glutamate transporter 1 on chronic constriction injury of sciatic nerve and morphine tolerance of rats].
    Yan H; Li CM; Li YL; Gong ZH
    Yao Xue Xue Bao; 2009 Jun; 44(6):581-5. PubMed ID: 19806886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal astrocyte gap junction and glutamate transporter expression contributes to a rat model of bortezomib-induced peripheral neuropathy.
    Robinson CR; Dougherty PM
    Neuroscience; 2015 Jan; 285():1-10. PubMed ID: 25446343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking.
    Knackstedt LA; Melendez RI; Kalivas PW
    Biol Psychiatry; 2010 Jan; 67(1):81-4. PubMed ID: 19717140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation.
    Rawls SM; Zielinski M; Patel H; Sacavage S; Baron DA; Patel D
    Drug Alcohol Depend; 2010 Mar; 107(2-3):261-3. PubMed ID: 20004063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease.
    Zumkehr J; Rodriguez-Ortiz CJ; Cheng D; Kieu Z; Wai T; Hawkins C; Kilian J; Lim SL; Medeiros R; Kitazawa M
    Neurobiol Aging; 2015 Jul; 36(7):2260-2271. PubMed ID: 25964214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats.
    Das SC; Yamamoto BK; Hristov AM; Sari Y
    Neuropharmacology; 2015 Oct; 97():67-74. PubMed ID: 26002627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Region-specific deletions of the glutamate transporter GLT1 differentially affect nerve injury-induced neuropathic pain in mice.
    Zhao Z; Hiraoka Y; Ogawa H; Tanaka K
    Glia; 2018 Sep; 66(9):1988-1998. PubMed ID: 29722912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftriaxone treatment after traumatic brain injury restores expression of the glutamate transporter, GLT-1, reduces regional gliosis, and reduces post-traumatic seizures in the rat.
    Goodrich GS; Kabakov AY; Hameed MQ; Dhamne SC; Rosenberg PA; Rotenberg A
    J Neurotrauma; 2013 Aug; 30(16):1434-41. PubMed ID: 23510201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.